54 related articles for article (PubMed ID: 14020054)
1. Chemical and histochemical analyses of tyrosinase activity in melanoma and related lesions.
CHANG JP; RUSSELL WO; STEHLIN JS; SMITH JL
Ann N Y Acad Sci; 1963 Feb; 100():951-64. PubMed ID: 14020054
[No Abstract] [Full Text] [Related]
2. [Study of the effect of progesterone on the tyrosinase activity of melanoma S 91 in mice].
Delacrétaz J
Dermatologica; 1966; 132(2):89-91. PubMed ID: 5955352
[No Abstract] [Full Text] [Related]
3. [Study on tyrosinase activity in experimental melanoma S 91 in mice and its variations on the effect of estradiol].
Delacrétaz J; Lerch P
Oncologia; 1965; 19(2):118-26. PubMed ID: 5862114
[No Abstract] [Full Text] [Related]
4. Separation and characterization of multiple forms of tyrosinase from mouse melanoma.
Burnett JB; Seiler H; Brown IV
Cancer Res; 1967 May; 27(5):880-9. PubMed ID: 4960889
[No Abstract] [Full Text] [Related]
5. Selective inhibition of growth and respiration of melanomas by tyrosinase inhibitors.
Demopoulos HB; Gerving MA; Bagdoyan H
J Natl Cancer Inst; 1965 Nov; 35(5):823-7. PubMed ID: 5849594
[No Abstract] [Full Text] [Related]
6. [Examination of serum tyrosinase-DOPA oxidase with the aid of the hydroquinone-p-benzoquinone system in hepatic melansarcoma].
Zălaru MC
Med Interna (Bucur); 1966 Oct; 18(10):1245-9. PubMed ID: 5978452
[No Abstract] [Full Text] [Related]
7. Identification of 3,4-dihydroxyphenylalanine as tyrosinase cofactor in melanoma.
Pomerantz SH; Warner MC
Biochem Biophys Res Commun; 1966 Jul; 24(1):25-31. PubMed ID: 4961079
[No Abstract] [Full Text] [Related]
8. A sensitive fluorometric assay method for mammalian tyrosinase.
Adachi K; Halprin KM
Biochem Biophys Res Commun; 1967 Jan; 26(2):242-6. PubMed ID: 6030270
[No Abstract] [Full Text] [Related]
9. [ANTITYROSINASE ACTIVITY OF THE SERUM OF PATIENTS WITH MALIGNANT MELANOMA: DEMONSTRATION WITH THE AID OF THE WARBURG APPARATUS].
GRUPPER C; LEGRAND JC; GONNARD P
Arch Klin Exp Dermatol; 1964 Jun; 219():784-9. PubMed ID: 14237740
[No Abstract] [Full Text] [Related]
10. [Influence of the "membrane permeability factor" on tyrosinase and DOPA-oxidase activity of the horse iris and ciliary body].
UGAZIO G; PANI P
Rass Med Sarda; 1962; 64():363-70. PubMed ID: 13995214
[No Abstract] [Full Text] [Related]
11. [Recent information on malignant melanomas].
Mikol C
Presse Med (1893); 1967 Apr; 75(21):1056. PubMed ID: 6024355
[No Abstract] [Full Text] [Related]
12. Histochemical demonstration of melanocytes by the use of 5,6-diacetoxyindole as substrate for tyrosinase.
Riley PA
Nature; 1967 Jan; 213(5072):190-1. PubMed ID: 6030582
[No Abstract] [Full Text] [Related]
13. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
Quaglino P; Osella-Abate S; Cappello N; Ortoncelli M; Nardò T; Fierro MT; Cavallo F; Savoia P; Bernengo MG
Melanoma Res; 2007 Apr; 17(2):75-82. PubMed ID: 17496782
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma.
Garnier JP; Letellier S; Cassinat B; Lebbé C; Kerob D; Baccard M; Morel P; Basset-Seguin N; Dubertret L; Bousquet B; Stoitchkov K; Le Bricon T
Eur J Cancer; 2007 Mar; 43(4):816-21. PubMed ID: 17276671
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo enzyme studies of polyhemoglobin-tyrosinase.
Yu B; Chang TM
Biotechnol Bioeng; 2004 Jun; 86(7):835-41. PubMed ID: 15162460
[TBL] [Abstract][Full Text] [Related]
17. Influence of N-glycan processing disruption on tyrosinase and melanin synthesis in HM3KO melanoma cells.
Choi H; Ahn S; Chang H; Cho NS; Joo K; Lee BG; Chang I; Hwang JS
Exp Dermatol; 2007 Feb; 16(2):110-7. PubMed ID: 17222224
[TBL] [Abstract][Full Text] [Related]
18. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
19. RT-PCR tyrosinase expression in the peripheral blood of melanoma patients.
Quaglino P; Savoia P; Osella-Abate S; Bernengo MG
Expert Rev Mol Diagn; 2004 Sep; 4(5):727-41. PubMed ID: 15347265
[TBL] [Abstract][Full Text] [Related]
20. Ferritin light chain down-modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation.
Maresca V; Flori E; Cardinali G; Briganti S; Lombardi D; Mileo AM; Paggi MG; Picardo M
J Cell Physiol; 2006 Mar; 206(3):843-8. PubMed ID: 16252260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
